跳转至内容
Merck
CN
  • Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: a comparison with carbamazepine, oxcarbazepine and lacosamide.

Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: a comparison with carbamazepine, oxcarbazepine and lacosamide.

Neuropharmacology (2014-09-23)
Simon Hebeisen, Nuno Pires, Ana I Loureiro, Maria João Bonifácio, Nuno Palma, Andrew Whyment, David Spanswick, Patrício Soares-da-Silva
摘要

This study aimed at evaluating the effects of eslicarbazepine, carbamazepine (CBZ), oxcarbazepine (OXC) and lacosamide (LCM) on the fast and slow inactivated states of voltage-gated sodium channels (VGSC). The anti-epileptiform activity was evaluated in mouse isolated hippocampal slices. The anticonvulsant effects were evaluated in MES and the 6-Hz psychomotor tests. The whole-cell patch-clamp technique was used to investigate the effects of eslicarbazepine, CBZ, OXC and LCM on sodium channels endogenously expressed in N1E-115 mouse neuroblastoma cells. CBZ and eslicarbazepine exhibit similar concentration dependent suppression of epileptiform activity in hippocampal slices. In N1E-115 mouse neuroblastoma cells, at a concentration of 250 μM, the voltage dependence of the fast inactivation was not influenced by eslicarbazepine, whereas LCM, CBZ and OXC shifted the V0.5 value (mV) by -4.8, -12.0 and -16.6, respectively. Eslicarbazepine- and LCM-treated fast-inactivated channels recovered similarly to control conditions, whereas CBZ- and OXC-treated channels required longer pulses to recover. CBZ, eslicarbazepine and LCM shifted the voltage dependence of the slow inactivation (V0.5, mV) by -4.6, -31.2 and -53.3, respectively. For eslicarbazepine, LCM, CBZ and OXC, the affinity to the slow inactivated state was 5.9, 10.4, 1.7 and 1.8 times higher than to the channels in the resting state, respectively. In conclusion, eslicarbazepine did not share with CBZ and OXC the ability to alter fast inactivation of VGSC. Both eslicarbazepine and LCM reduce VGSC availability through enhancement of slow inactivation, but LCM demonstrated higher interaction with VGSC in the resting state and with fast inactivation gating.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
十二烷基硫酸钠, BioReagent, suitable for electrophoresis, Molecular Biology, ≥98.5% (GC)
Sigma-Aldrich
十二烷基硫酸钠, ≥99.0% (GC), dust-free pellets
Sigma-Aldrich
十二烷基硫酸钠, ACS reagent, ≥99.0%
Sigma-Aldrich
十二烷基硫酸钠 溶液, BioUltra, Molecular Biology, 10% in H2O
Sigma-Aldrich
十二烷基硫酸钠, ReagentPlus®, ≥98.5% (GC)
Sigma-Aldrich
十二烷基硫酸钠, BioUltra, Molecular Biology, ≥99.0% (GC)
Sigma-Aldrich
十二烷基硫酸钠 溶液, BioUltra, 20% in H2O
Supelco
十二烷基硫酸钠, dust-free pellets, suitable for electrophoresis, Molecular Biology, ≥99.0% (GC)
Supelco
十二烷基硫酸钠, suitable for ion pair chromatography, LiChropur, ≥99.0%
Sigma-Aldrich
十二烷基硫酸钠, BioXtra, ≥99.0% (GC)
Sigma-Aldrich
十二烷基硫酸钠, ≥98.0% (GC)
Sigma-Aldrich
十二烷基硫酸钠, 92.5-100.5% based on total alkyl sulfate content basis
Sigma-Aldrich
MES 溶液, BioUltra, Molecular Biology, 0.5 M in H2O
Sigma-Aldrich
十二烷基硫酸钠, ≥90% ((Assay))
Sigma-Aldrich
十二烷基硫酸钠, tested according to NF, mixture of sodium alkyl sulfates consisting mainly of sodium dodecyl sulfate
Supelco
卡马西平, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
卡马西平, analytical standard
USP
卡马西平, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
奥卡西平, ≥98% (HPLC), solid
月桂基硫酸钠, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
卡马西平, meets USP testing specifications
USP
奥卡西平, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
十二烷基硫酸钠, BioReagent, Molecular Biology, ≥98.5% (GC), free-flowing, Redi-Dri
卡马西平, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
十二烷基硫酸钠, Vetec, reagent grade, ≥98%
奥卡西平, European Pharmacopoeia (EP) Reference Standard